首页 > SCI期刊 > SCIE期刊 > JCRQ1 > 期刊先容
评估信息:
影响因子:3
年发文量:66
《结直肠病学年鉴》(Annals Of Coloproctology)是一本以Multiple综合研讨为特点的国际期刊。该刊由Korean Society of Coloproctology出书商该刊已被国际主要权势巨子数据库SCIE收录。期刊聚焦Multiple范畴的重点研讨和前沿停顿,实时刊载和报道该范畴的研讨功效,努力于成为该范畴同业停止疾速学术交换的信息窗口与平台。该刊2023年影响因子为3。CiteScore指数值为3.3。
Annals of Coloproctology is an academic journal dedicated to the field of colorectal disease, providing a platform for researchers, clinical doctors, and related medical professionals to exchange and share the latest research results, clinical experience, technological advancements, and treatment strategies. This journal aims to promote the dissemination of knowledge and professional development in the field of colorectal diseases, particularly in the research and treatment of colorectal cancer, inflammatory bowel disease, functional bowel disease, pelvic floor dysfunction, and other related diseases. Journal content typically includes original research papers, review articles, technical reports, clinical case analyses, and reviews, covering a wide range of topics such as molecular biology of colorectal cancer, genetics, diagnostic techniques, surgical methods, radiotherapy and chemotherapy strategies, and management of inflammatory bowel disease.
The editorial team of the journal is usually composed of experts and scholars in the field of colorectal diseases, who are responsible for the editorial work of the journal, including article collection, peer review, and final publication. The journal adopts a strict peer review process to ensure that the published articles have high quality and academic value. Due to the interdisciplinary nature of colorectal diseases, including surgery, internal medicine, radiology, pathology, and basic sciences, the journal provides readers with an opportunity to understand colorectal diseases and treatment methods from multiple perspectives. By reading and publishing articles in this journal, readers can learn about the latest research trends in colorectal diseases, innovations in clinical practice, and improvements in treatment strategies.
《结直肠病学年鉴》是一本专一于结直肠病学范畴的学术期刊,它为结直肠病学的研讨者、临床大夫和相干医疗专业职员供给了一个交换和分享最新研讨功效、临床经历、手艺停顿和医治战略的平台。该期刊旨在鞭策结直肠病学范畴的常识传布和专业成长,出格是在结直肠癌、炎症性肠病、功效性肠病、盆底功效妨碍和其余相干疾病的研讨和医治方面。期刊内容凡是包含首创研讨论文、综述文章、手艺报告、临床案例阐发和批评,涵盖了普遍的主题,如结直肠癌的份子生物学、遗传学、诊断手艺、外科手术体例、放疗和化疗战略、和炎症性肠病的办理等。
杂志的编辑团队凡是由结直肠病学范畴的专家和学者构成,他们担任期刊的编辑任务,包含文章的征集、同业评审和终究的出书。期刊接纳严酷的同业评审流程,确保颁发的文章具备高品质和学术代价。因为结直肠病学是一个触及多学科穿插的范畴,包含外科、外科、喷射学、病理学和根本迷信等,杂志为读者供给了一个多角度懂得结直肠疾病和医治体例的机遇。经由过程浏览和颁发在该期刊上的文章,读者可以或许领会结直肠病学的最新研讨趋向、临床理论的立异和医治战略的改良。
若是您须要辅佐投稿或润稿办事,您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年,熟习颁发政策,可为您供给一对一投稿指点,防止您在投稿时频仍碰鼻,节流您的可贵时候,有用晋升颁发机率,确保SCI检索(检索不了全额退款)。咱们视诺言为生命,多方面确保文章宁静失密,在任何环境下都不会泄漏您的小我信息或稿件内容。
JCR分区品级:Q1
按JIF目标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
学科:GASTROENTEROLOGY & HEPATOLOGY | ESCI | Q2 | 54 / 143 |
62.6% |
学科:SURGERY | ESCI | Q1 | 47 / 290 |
84% |
按JCI目标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
学科:GASTROENTEROLOGY & HEPATOLOGY | ESCI | Q2 | 42 / 143 |
70.98% |
学科:SURGERY | ESCI | Q2 | 100 / 290 |
65.69% |
Gold OA文章占比 | 研讨类文章占比 | 文章自引率 |
99.49% | 84.85% | |
开源占比 | 出书国人文章占比 | OA被援用占比 |
名词诠释:JCR分区在学术期刊评估、科研功效展现、科研标的目的指导和学术交换与协作等方面都具备主要的代价。经由过程对期刊影响因子的切确计较和详尽分别,JCR分区可以或许清楚地反应出差别期刊在统一学科范畴内的绝对地位,从而赞助科研职员精确辨认出高品质的学术期刊。
CiteScore | SJR | SNIP | CiteScore 指数 | ||||||||||||
3.3 | 0.481 | 0.855 |
|
名词诠释:CiteScore是基于Scopus数据库的全新期刊评估系统。CiteScore 2021 的计较体例是期刊比来4年(含计较年度)的被引次数除以该期刊近四年颁发的文献数。CiteScore基于环球最普遍的择要和引文数据库Scopus,合用于一切持续出书物,而不只仅是期刊。今朝CiteScore 收录了跨越 26000 种期刊,比取得影响因子的期刊多13000种。被各界人士以为是影响因子最无力的合作敌手。
积年IF值(影响因子)
积年引文目标和发文量
积年自引数据
若用户须要出书办事,请接洽出书商。